276 related articles for article (PubMed ID: 9257301)
21. Studies of blood coagulation-fibrinolysis regarding kallikrein-kinin system in severe preeclampsia.
Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
Agents Actions Suppl; 1992; 38 ( Pt 2)():342-9. PubMed ID: 1462840
[TBL] [Abstract][Full Text] [Related]
22. Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus.
Kwieciński J; Kłak M; Trysberg E; Blennow K; Tarkowski A; Jin T
Arthritis Rheum; 2009 Jul; 60(7):2094-101. PubMed ID: 19565516
[TBL] [Abstract][Full Text] [Related]
23. D-dimer predicts outcome after aneurysmal subarachnoid hemorrhage: no effect of thromboprophylaxis on coagulation activity.
Ilveskero S; Juvela S; Siironen J; Lassila R
Neurosurgery; 2005 Jul; 57(1):16-24; discussion 16-24. PubMed ID: 15987536
[TBL] [Abstract][Full Text] [Related]
24. Thrombin activity in CSF after SAH is correlated with the degree of SAH the persistence of subarachnoid clot and the development of vasospasm.
Kasuya H; Shimizu T; Takakura K
Acta Neurochir (Wien); 1998; 140(6):579-84. PubMed ID: 9755325
[TBL] [Abstract][Full Text] [Related]
25. Monitoring of fibrin and fibrinogen degradation products (FDP) in the cerebrospinal fluid of patients with subarachnoid haemorrhage due to ruptured aneurysm. Report of 55 cases.
Schisano G; Franco A; Nina P; Papa ML; Iannuzzi M; De Biase R; Caldora M
J Neurosurg Sci; 1994 Jun; 38(2):77-86. PubMed ID: 7891197
[TBL] [Abstract][Full Text] [Related]
26. [The relationship between the severity of a neurological condition and the blood coagulation/fibrinolytic system in patients with spontaneous subarachnoid hemorrhage].
Kusanagi H; Teramoto A; Shimura T
No Shinkei Geka; 2002 Apr; 30(4):399-403. PubMed ID: 11968826
[TBL] [Abstract][Full Text] [Related]
27. Platelet-activating factor (PAF) concentration and PAF acetylhydrolase activity in cerebrospinal fluid of patients with subarachnoid hemorrhage.
Hirashima Y; Endo S; Ohmori T; Kato R; Takaku A
J Neurosurg; 1994 Jan; 80(1):31-6. PubMed ID: 8271019
[TBL] [Abstract][Full Text] [Related]
28. Effect of intrathecal thrombolytic therapy on subarachnoid clot and chronic vasospasm in a primate model of SAH.
Findlay JM; Weir BK; Steinke D; Tanabe T; Gordon P; Grace M
J Neurosurg; 1988 Nov; 69(5):723-35. PubMed ID: 3141595
[TBL] [Abstract][Full Text] [Related]
29. Recognition of Plasminogen Activator Inhibitor Type 1 as the Primary Regulator of Fibrinolysis.
Urano T; Suzuki Y; Iwaki T; Sano H; Honkura N; Castellino FJ
Curr Drug Targets; 2019; 20(16):1695-1701. PubMed ID: 31309890
[TBL] [Abstract][Full Text] [Related]
30. Activation of the coagulation system in the subarachnoid space after subarachnoid haemorrhage: serial measurement of fibrinopeptide A and bradykinin of cerebrospinal fluid and plasma in patients with subarachnoid haemorrhage.
Kasuya H; Shimizu T; Okada T; Takahashi K; Summerville T; Kitamura K
Acta Neurochir (Wien); 1988; 91(3-4):120-5. PubMed ID: 3407455
[TBL] [Abstract][Full Text] [Related]
31. Association of an endogenous inhibitor of nitric oxide synthase with cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage.
Jung CS; Oldfield EH; Harvey-White J; Espey MG; Zimmermann M; Seifert V; Pluta RM
J Neurosurg; 2007 Nov; 107(5):945-50. PubMed ID: 17977265
[TBL] [Abstract][Full Text] [Related]
32. Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex as risk factors for the development of a first stroke.
Johansson L; Jansson JH; Boman K; Nilsson TK; Stegmayr B; Hallmans G
Stroke; 2000 Jan; 31(1):26-32. PubMed ID: 10625711
[TBL] [Abstract][Full Text] [Related]
33. Combined cisternal drainage and intrathecal urokinase injection therapy for prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage.
Moriyama E; Matsumoto Y; Meguro T; Kawada S; Mandai S; Gohda Y; Sakurai M
Neurol Med Chir (Tokyo); 1995 Oct; 35(10):732-6. PubMed ID: 8532128
[TBL] [Abstract][Full Text] [Related]
34. Early treatment of subarachnoid hemorrhage after preventing rerupture of an aneurysm.
Kinugasa K; Kamata I; Hirotsune N; Tokunaga K; Sugiu K; Handa A; Nakashima H; Ohmoto T; Mandai S; Matsumoto Y
J Neurosurg; 1995 Jul; 83(1):34-41. PubMed ID: 7782847
[TBL] [Abstract][Full Text] [Related]
35. Quantitative determination of plasma fibrinolytic activity in patients with ruptured intracranial aneurysms who are receiving epsilon-aminocaproic acid: relationship of possible complications of therapy to the degree of fibrinolytic inhibition.
Burchiel KJ; Hoffman JM; Bakay RA
Neurosurgery; 1984 Jan; 14(1):57-63. PubMed ID: 6537999
[TBL] [Abstract][Full Text] [Related]
36. Cerebrospinal fluid tissue factor and thrombin-antithrombin III complex as indicators of tissue injury after subarachnoid hemorrhage.
Hirashima Y; Nakamura S; Suzuki M; Kurimoto M; Endo S; Ogawa A; Takaku A
Stroke; 1997 Sep; 28(9):1666-70. PubMed ID: 9303007
[TBL] [Abstract][Full Text] [Related]
37. Alterations in perivascular dilatory neuropeptides (CGRP, SP, VIP) in the external jugular vein and in the cerebrospinal fluid following subarachnoid haemorrhage in man.
Juul R; Hara H; Gisvold SE; Brubakk AO; Fredriksen TA; Waldemar G; Schmidt JF; Ekman R; Edvinsson L
Acta Neurochir (Wien); 1995; 132(1-3):32-41. PubMed ID: 7538726
[TBL] [Abstract][Full Text] [Related]
38. CSF smooth-muscle constrictor activity associated with cerebral vasospasm and mortality in SAH patients.
Kaye AH; Tagari PC; Teddy PJ; Adams CB; Blaso WP; Boullin DJ
J Neurosurg; 1984 May; 60(5):927-34. PubMed ID: 6716160
[TBL] [Abstract][Full Text] [Related]
39. Platelet function and fibrinolytic activity in patients with bronchial asthma.
Tutluoglu B; Gurel CB; Ozdas SB; Musellim B; Erturan S; Anakkaya AN; Kilinc G; Ulutin T
Clin Appl Thromb Hemost; 2005 Jan; 11(1):77-81. PubMed ID: 15678276
[TBL] [Abstract][Full Text] [Related]
40. Changes in coagulative and fibrinolytic activities in patients with intracranial hemorrhage.
Ebihara T; Kinoshita K; Utagawa A; Sakurai A; Furukawa M; Kitahata Y; Tominaga Y; Chiba N; Moriya T; Nagao K; Tanjoh K
Acta Neurochir Suppl; 2006; 96():69-73. PubMed ID: 16671428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
